VDAC1 and glaucoma: It is also clear that the isoforms’ expression changes in several major retinal degenerative diseases and in certain models of glaucoma; blocking VDAC oligomerization prevents apoptosis of RGCs, making this approach an attractive therapeutic target of glaucoma.